Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4151561 | 0.83 | TDP1 (0.67) | TDP1ALDH1A1TSHRHTTCYP2C19 | |
| SCHEMBL6447185 | 0.80 | TDP1 (0.69) | TDP1ALDH1A1TSHRHTTCYP2C19 | |
| Sumiki'S Acid SCHEMBL50822 | 0.80 | TDP1 (1.00) | TDP1ALDH1A1TSHRHTTSMN1; SMN2 | |
| Sumiki'S Acid SCHEMBL29706392 | 0.80 | TDP1 (1.00) | TDP1ALDH1A1TSHRHTTSMN1; SMN2 | |
| SCHEMBL855399 | 0.78 | TDP1 (0.67) | TDP1ALDH1A1TSHRHTTCYP2C19 | |
| SCHEMBL21525922 | 0.78 | TDP1 (0.67) | TDP1ALDH1A1TSHRHTTCYP2C19 | |
| SCHEMBL28365066 | 0.75 | TDP1 (0.62) | TDP1ALDH1A1TSHRHTTCYP2C19 | |
| SCHEMBL17514990 | 0.74 | TDP1 (0.60) | TDP1ALDH1A1TSHRHPGDSMN1; SMN2 | |
| SCHEMBL17491868 | 0.74 | TDP1 (0.66) | TDP1ALDH1A1TSHRHTTHPGD | |
| SCHEMBL13451413 | 0.74 | ALDH1A1 (0.62) | TDP1ALDH1A1TSHRHTTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795154-B2 | Method for the synthesis of 2,5-furandicarboxylic acid | SAMYANG CORPORATION (KR) | 2023-10-24 | — | — | US | disclosed |
| US-20220162179-A1 | METHOD FOR THE SYNTHESIS OF 2,5-FURANDICARBOXYLIC ACID | SAMYANG CORPORATION (KR) | 2022-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162179-A1 | METHOD FOR THE SYNTHESIS OF 2,5-FURANDICARBOXYLIC ACID | HPD, GRHPR, HAAO | TDP1 3560/4885ALDH1A1 592/4885TSHR 4297/4885 |
| US-11795154-B2 | Method for the synthesis of 2,5-furandicarboxylic acid | HPD, GRHPR, HAAO | TDP1 3560/4885ALDH1A1 592/4885TSHR 4297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.